Since the time you follow us on Croblanc, you are beginning to be used to hear about the Youtube channel Bloomberg Technology, and its viral videos that are always talked about on the web, and even beyond! Sometimes we hesitate to write an article because we don't know if you will like it, but today we know that this video will interest you.
We propose you today to find the last video of the Youtube channel Bloomberg Technology which is simply called Scribe Inks CRISPR Gene-Editing Deal with Prevail. If you liked it, don't hesitate to like the content to support the author of the video!
We could find in the next hours this content in the trend tool of Youtube because of the start that it makes! Since the Youtube channel Bloomberg Technology posted it, many people are talking about it on the networks. Let's wait for a few hours before we know how successful this video is.
Sometimes when we watch a video on the internet, we can have some feedback to give to the content creator. To tell him about a problem or an error that we discovered for example. However, there is no guarantee that they will respond. But nothing ventured, nothing gained! To get in direct contact with a videographer, try to find his social networks and send him a public or private message. You can also find the email of a Youtuber on his Youtube channel by clicking on "About". This will give you his precious email address.
We are almost at the end of the news about the video Scribe Inks CRISPR Gene-Editing Deal with Prevail, all the team Croblanc hopes that you found it interesting to read. In our platform, you can find other videos of Bloomberg Technology, take a look at it occasionally, it's practical and it can allow you to find contents that you had never seen before on the web!
Friends, this is already the end of this little editorial, see you soon for a new article on Croblanc!
For your information, you can find below the description of the video Scribe Inks CRISPR Gene-Editing Deal with Prevail published by the Youtube channel Bloomberg Technology:
CRISPR pioneer Jennifer Doudna's company Scribe Therapeutics inked a major deal with Prevail Therapeutics potentially worth $1.5 billion to create genetic medicines for neurological and neuromuscular diseases. Scribe CEO Ben Oakes joins Caroline Hyde for more.
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here: https://tinyurl.com/ycyevxda
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on...